Systematic reviews of postoperative pain in children have called into question the consistency of outcomes measured by clinical triallists as well as the measurement instruments used for assessment. Core outcome set methodology may be a solution to improve standardisation. This study provides an evidence-based foundation for the development of a core outcome set for paediatric postoperative pain studies. We searched ClinicalTrials.gov to identify relevant postoperative pain studies in children. The search yielded 300 registered trials. The following data were then extracted from each of the trials: phase of trial; study type; study design; sample size; all outcomes; whether the outcome was listed as primary, secondary, or tertiary; the measurement instrument for each reported outcome; the specific metric for each outcome; and the type of clinical procedure. Following screening, 134 studies were included in our study. Pain measurement was the most commonly reported outcome (n = 123), followed by total postoperative analgesic dosage (n = 83) and side-effects (n = 25). Temporal trends indicated that pain assessment and unexpected events increased in use between 2000 and 2016, whereas postoperative analgesia measurement decreased. We found a lack of standardisation among outcomes and measurement instruments in paediatric postoperative pain studies.
Introduction
Pain assessment is an important aspect of postoperative patient care. Accurate assessment informs pain management decisions, such as whether analgesic dose changes are needed or whether changes to the management plan are warranted [1] . Not surprisingly, there are several recognised measurement challenges with the use of children's self-reported measures of pain [2, 3] . Developmental age or chronic disease may limit a child's ability to report pain, and the effects of sedation, analgesics or anaesthetics may have a similar effect [4] . The subjective nature of pain also operative pain is not only a significant source of anxiety for both parent and child [5] but also a contributor to overall morbidity, evaluating it in the most consistent way possible across a continuum of care is an important therapeutic goal.
Although pain measurement is complicated in the clinical setting, it is equally challenging in clinical trials where standardised measurement is needed across patients [6] . Systematic reviews of postoperative pain management highlight these challenges. For example, a Cochrane systematic review of tramadol for postoperative pain treatment in children found that many trials had used unvalidated pain scales as outcome measures; the resulting evidence from these trials was rated as very low quality by reviewers [7] . A further Cochrane systematic review [8] examining the effect of pre-and postoperative local anaesthesia on pain reduction following tonsillectomy reported that although some primary studies used validated pain scales or supplemental analgesic intake to evaluate pain, others used inappropriate measures, such as calculating a post-hoc global pain score. Such studies were excluded due to a high likelihood of bias. This review also reported different time-points for pain assessment across studies; reviewers were unable to conduct a meta-analysis due to these inconsistencies. These examples illustrate a lack of consistency in postoperative pain measurement and suggest the need for improved standardisation of outcomes as well as the careful selection of measurement instruments with sound psychometric properties for postoperative pain studies.
Core outcome set methodology could address this lack of standardisation. A core outcome set is a minimum set of outcomes recommended for measurement across all trials of a particular medical condition [9] . The development of a core outcome set first involves mapping the outcomes most frequently used by triallists. Next, consensus methods, with participation from clinical triallists, systematic reviews, content experts, methodologists, patients, funding agencies and other research stakeholders are used to derive a set of proposed standardised outcomes [10] . Standardised outcomes allow for a more accurate comparison between studies and improve the quality of systematic reviews. Anaestheric researchers are beginning to address core outcome set development. The Standardized Endpoints for Perioperative Medicine (StEP) Group and the Core Outcomes Measures in Perioperative and Anaesthetic Care (COMPAC) initiative are current working groups intending to standardise the criteria for, and selection of, measurement instruments, in order to promote standardisation of outcomes for systematic reviews and data synthesis [11] . Furthermore, the Pediatric Acute and Chronic/Recurrent Pain Clinical Trials Group (PedIMMPACT) is working towards solutions to improving pain measurement in paediatric patients. Here, we aim to apply the initial step of the development process by conducting a systematic review of outcomes reported in clinical trials of paediatric postoperative pain. The specific aims of this study are to: determine outcomes most frequently measured by researchers studying postoperative pain management in children and adolescents; to catalogue the measurement instruments (and associated metrics) used to assess them; to examine temporal trends in outcome measurement by broader domains; and to identify outcomes most often measured with (or connected to) other outcomes reported in studies.
Methods
We conducted a systematic review to identify outcomes reported in registered clinical trials and observational studies. This study did not meet the regulatory definition of human subject research as defined in 45 CFR 46.102(d) and (f) of the Department of Health and Human Services' Code of Federal Regulations [12] and, therefore, was not subject to Institutional Review Board oversight. As we developed our methodology, we consulted Li et al. [13] , the Cochrane Handbook for Systematic Reviews of Interventions [14] , and the National Academies of Science, Engineering, and Medicine's (formerly the Institute of Medicine) Standards for Systematic Reviews [15] for best practices in data collection and management for systematic reviews. We applied relevant PRISMA guidelines [16] or systematic reviews and SAMPL guidelines [17] for reporting descriptive statistics to ensure best practices in reporting study information.
Primary studies registered in the ClinicalTrials.gov trial registry involving the use of an intervention for postoperative pain management in patients from birth to the age of 18 years were eligible for this study. We included randomised and non-randomised clinical trials and observational studies. Both clinical trials and observational studies were included since studies using these designs are registered on ClinicalTrials.gov [18] . Both open (not yet recruiting, recruiting) and closed (active, not recruiting; completed; terminated; suspended; withdrawn; enrolling by invitation) trials were considered for inclusion. We used the National Institutes of Health definition of a clinical trial: "a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioural outcomes" [19] . Observational studies were defined as "a biomedical or behavioural research study of human subjects designed to assess risk factors for disease development or progression, assess natural history of risk factors or disease, identify variations based on geographic or personal characteristics (such as race/ethnicity or gender), track temporal trends, or describe patterns of clinical care and treatment in absence of specific study-mandated interventions" [19] .
A ClinicalTrials.gov (1 January 2000-16 November 2015) search, in consultation with an information specialist, was conducted to identify clinical trials and observational studies that investigated postoperative pain management in children and adolescents. We did not restrict the search by language, trial status, trial phase, recruitment phase, study type, funding type or location. We used the child age-group limiter to narrow search results to studies with paediatric and adolescent samples. The final search was deployed as follows: (postoperative OR "post operative" OR "postoperative" OR "post surg*" OR "post-surg*") AND (analges* OR "pain management") | Child | received from 01 January 2000 to 16 November 2015. The search took place on 16 November 2015.
Registered studies yielded by the search were screened for eligibility based on title and study description. The first (AR), second (JY), fourth (GA) and fifth (AD) investigators screened studies for eligibility by working in pairs. Within each pair, one investigator made an initial evaluation regarding eligibility, and this evaluation was either confirmed or challenged by the other investigator. Any discrepancy was resolved by discussion, and when required, the arbitration of the senior investigator (MV). A study flow diagram outlines the final exclusions ( Fig. 1) .
Before data abstraction, a manual was created to standardise practices, define the data elements, and present examples of likely scenarios. An electronic form was also created to further standardise the process. All authors attended a series of meetings to apply the abstraction manual and form to a sample of studies as a pilot test before launch. Studies were examined as a group and outcomes were abstracted based on group consensus. After the investigators agreed on a final version of the abstraction manual and data form, revisions were made and studies were divided equally among AR, JY, GA and AD. Each investigator abstracted data from registered studies and then verified the data of his partner. Disagreements between the initially abstracted and verified data were adjudicated by discussion between the investigator pair. After this process was completed, AR and JY jointly reviewed all abstracted data from all investigators a third time together to ensure the accuracy and integrity of the data for this study. We consulted several sources when developing the abstraction manual [18, [20] [21] [22] [23] [24] . The following data elements were abstracted from each study: phase of trial; study type; study design; sample size; all outcomes; whether the outcome was listed as primary, secondary or tertiary; the measurement device; the specific metric for each outcome; and the type of clinical procedure. We defined an outcome as the exact word-for-word terms (presented as either a primary or secondary outcome) in a registered study on ClinicalTrials.gov for any clinical end-point, or physiological, metabolic or mortality event measured by clinicians or researchers [24] . Final outcomes were then standardised to improve the consistency of naming. For example, 'objective pain score' was changed to 'pain measurement'. After the outcomes had been standardised, we placed them in broader domains. These domains were developed with the help of AS, a board-certified anaesthetist.
We summarised results using frequencies and percentages for outcomes. Stata 13.1 [25] was used to produce descriptive statistics for study results. Stata's lowess command was used to derive the locally weighted scatterplot smoothing for outcome domain use over time. Analysis for examining outcomes most central to the network are described below.
Results
Our initial search yielded 300 registered clinical studies. After screening, 134 trials were excluded for including adult patients in their sample. Out of the 166 trials studying children, 14 were focused on pharmacodynamic and pharmacokinetic properties of drugs and were subsequently excluded. A total of 152 trials were included in our final sample (Fig. 1) .
Almost one-half (74, 49%) of the trials included for this review were listed as completed according to ClinicalTrials.gov. The remaining trials were at various stages, with 35 (23%) of those remaining trials in the recruiting stage. One hundred and thirty-eight (91%) were intervention studies; 11 (7%) were observational, two (1%) epidemiological and one (1%) of diagnostic accuracy ( Table 1) .
The most frequently reported surgical procedures for postoperative pain evaluation were 20 studies of orthopaedic operations (13%), 17 (11%) of adenotonsillectomy/ tonsillectomy, 15 (10%) of hernia repair, 11 (7%) unspecified and seven (5%) appendicectomy (Table 1) .
We organised the 152 postoperative pain trials into 12 different outcome domain categories that account for a total of 563 reported outcomes. A summary of the specific outcomes reported within each domain category, the measurement instruments used and the metric for the devices used within each domain category, are presented in Table 2 .
The most commonly reported outcome was pain measurement (123 studies; 60 as primary, 63 as secondary), followed by the total analgesic dosage postoperatively (83 studies, 48 as primary, 35 as secondary), and side-effects (26 studies, one as primary, 24 as secondary, one unspecified (Table 3) . Pain measurement was a primary outcome for 63 trials and a secondary outcome for 60 trials. Total analgesic dosage was a primary outcome for 48 trials and a secondary outcome for 35 trials. Side-effects were a primary outcome for one trial, secondary outcome for 25 trials and unspecified in one trial. The latter two outcomes were measured by the total dosage and observation, respectively. The FLACC tool ('faces, legs, activity, cry and consolability') was most often reported among the named instruments for pain assessment. However, the specific instrument used for postoperative pain assessment was unclear for the majority of reported outcomes in the trials.
There was a median of three outcomes reported per trial, with a range between one and 15 outcomes reported per trial. As a result, secondary outcomes were a commonly reported feature, accounting for 359 (64%) of the 563 total outcomes. A summary of outcome characteristics is presented in Table 4 .
Our analysis of outcome usage in trials over time suggested that the use of measurement of pain assessment, and unexpected events increased from 2000 to 2016, with pain assessment showing the greatest increase. However, the measurement of postoperative analgesia as an outcome domain decreased. The reported measurements of the other nine outcome domains were stable over this time period. Scatterplots displaying the trends are shown in the Supporting Information Fig. S1 .
Discussion
Results from this study document the lack of standardisation of outcomes in postoperative pain studies in paediatric patients. The diversity of outcomes reported across studies could limit study-to-study comparisons to the few outcomes that are most consistently reported, regardless of their importance to various research stakeholders. Systematic reviewers may be forced to omit important outcomes from data synthesis if particular outcomes were only rarely measured in primary studies. Previous evidence underscores the importance of methodological validity of systematic reviews [26] and results from this investigation provide further support for needed mechanisms to improve methodological quality. Additionally, clinicians will be better able to care for patients if research studies have a standardised approach to outcome measurement and will be able to apply therapeutic protocols that have documented effectiveness based on standardised investigations. A core outcome set for postoperative pain in children would directly address these issues and is greatly needed.
During core outcome set development, a review of previous trials or systematic reviews is a necessary first step to understand the variety of outcomes and measurement instruments currently in use [9] . After this baseline information has been established, key research stakeholders are identified and brought together to begin the development process. These stakeholders include, but are not limited to, clinical triallists, systematic reviewers, funders, clinicians, methodologists and patients. Consensus methods (such as the Delphi process) are used to narrow the outcomes to those few considered most important across all stakeholder groups. Also, for systematic reviews it may not be necessary to specify whether or not these are primary or secondary outcomes. Instead, all outcomes should undergo the same testing and be adjusted for their level of significance [27] . Measurement instruments for these outcomes are next considered based on the psychometric body of evidence. In some cases, specific measurement instruments may be recommended based upon substantial evidence supporting valid and reliable scores. In other instances, such information is not available and psychometric studies will be needed to establish such evidence. As a final step, action should be taken to ensure adoption and implementation of core outcome sets, as well as continuous monitoring thereafter to ensure that outcomes and devices remain up to date and relevant. The PedIMMPACT Group conducted a Delphi study in 2008 to identify outcomes important for measurement in paediatric pain trials [28] . Findings from this study suggest that "investigators conducting paediatric acute pain clinical trials should consider assessing outcomes in pain intensity; global judgment of satisfaction with treatment; symptoms and adverse events; (27) Blood pressure (3/27) Unclear (13/27) Value at a time-point (19/27) Heart rate (3/27) Vitals (3/27) Pharmacological (26) Clearance ( Expanded table available at https://doi.org/10.6084/m9.figshare.5603128.v1. FLACC, 'faces, legs, activity, cry and consolability'; IMP, investigational medicinal product; OSA, obstructive sleep apnoea. physical recovery; emotional response; and economic factors. There was also agreement that investigators conducting paediatric clinical trials in chronic and recurrent pain should consider assessing outcomes in pain intensity; physical functioning; emotional functioning; role functioning; symptoms and adverse events; global judgment of satisfaction with treatment; sleep; and economic factors." Our study found that some of the suggestions by the PedIMPPACT group were not being incorporated into trials. This could be an indication that they are not known about or are not being followed. Specifically, the studies included in this systematic review did not include measurement of emotional response and functioning, economic factors, role functions or sleep.
The PedIMMPACT study also provided recommendations for assessment instruments, and it recommended use of the FLACC ('faces, legs, activity, cry and consolability') scale for children who are at least one year old. The authors state that 'there are extensive reliability and validity data on the FLACC' and cite two studies in support of this statement [29, 30] . These studies, however, were based on small sample sizes (89 and 147 children, respectively) and criticisms of the FLACC scale were not considered. In a recent systematic review of psychometric evidence for the FLACC scale, a number of validity criticisms were raised [31] . First, 'jaw clenching' and 'chin quivering' -both used on the FLACC scale -are rarely features of infants expressing pain. Second, it is not clear in the scale description how efforts should be made to console the child before scoring the consolability item. This item may be especially difficult in cases where conducting a procedure may limit attempts to console the child. Last, no rigorous investigations have been conducted to evaluate the descriptors for the scale items as well as the item scoring, raising questions about the accuracy of the descriptors. This systematic review concluded that "limited and conflicting data addressing procedural pain assessment exist. Content validity and scale feasibility have had limited psychometric evaluation. There are insufficient data to support the FLACC scale for use in all circumstances and populations to which is currently applied." Despite insufficient evidence for the FLACC, our study shows that the FLACC is still the most frequently used instrument reported in different children's studies. In the development of core outcome sets, careful attention should be paid to the specific measurement instruments recommended. These measurement instruments should have evidence that scores are valid and reliable in the population of interest [32] . The COSMIN checklist [33] is used to evaluate psychometric studies, and we recommend its application to measurement instruments before recommendations are made.
The lack of standardisation of pain outcomes is not limited to paediatric populations, however. A recent systematic review of propofol for postoperative pain reported that seven primary studies could not be included as the different pain scoring systems were not interconvertible [34] . This lack of consistency in pain measurement in adults suggests that standardisation for pain assessment is needed in all patient groups.
A previous study related to the development of a core set of outcomes highlighted the need for consistent and periodic review of these sets [23] . By doing so, these reviews will ensure studies continue to report outcomes that will have the greatest impact on clinical decision making. Considering the wide array of outcomes reported in clinical trials over the past 15 years in the area of paediatric postoperative pain management, our study indicates the same need. It is apparent that outcomes which appear most relevant today, may no longer have a clinical impact at a future time, and new or previously dismissed outcomes may become critical in this process. Our study is not without limitations. We used outcomes reported in ClinicalTrials.gov in this study based on suggestions from Clark and Williamson [9, 35] . We made this decision so that our study included the latest outcomes from ongoing studies, while at the same time attempting to limit selective outcome reporting bias. Although there are strengths to registry-listed outcomes, there are also challenges. Previous research indicates that ClinicalTrials.gov registrations may be vague and incomplete in reporting outcomes [35] . This problem has been addressed by WHO's International Registration Standards and even ClinicalTrials.gov itself. In order for researchers and systematic reviewers to make best use of the registry, more complete entries are needed. The Department of Health and Human Services has recently proposed a requirement for clinical triallists to provide a specific measurement, specific metric and time frame on registration [36] . Requirements like these are necessary to solve the problems in reporting clinical trials and are a step towards the solution. Furthermore, we were not able to comment on age or development-specific measurement for pain. Many of the studies catalogued in ClinicalTrials.gov listed wide age ranges for participant eligibility. This limited our ability to stratify outcomes and measurement instruments by age, which is an important consideration in postoperative pain assessment in paediatric populations.
In summary, a lack of standardisation in outcome measurement is a notable concern in paediatric postoperative pain studies. One solution to this issue is to develop a core set of outcomes that could be measured across trials. These outcomes could then be combined in a systematic review. Furthermore, the comprehensive process used for core outcome set development allows for input from relevant research stakeholders, including patients, or in the case of paediatric patients, their parents. As clinical research moves towards patient-centred outcomes, it is important for triallists to include outcomes important to patients as well as more traditional pain-related outcomes.
